How cells monitor the integrity of their translation apparatus

Information

  • Research Project
  • 10018938
  • ApplicationId
    10018938
  • Core Project Number
    DP5OD028147
  • Full Project Number
    5DP5OD028147-02
  • Serial Number
    028147
  • FOA Number
    RFA-RM-18-010
  • Sub Project Id
  • Project Start Date
    9/16/2019 - 5 years ago
  • Project End Date
    8/31/2024 - 6 months ago
  • Program Officer Name
    MILLER, BECKY
  • Budget Start Date
    9/1/2020 - 4 years ago
  • Budget End Date
    8/31/2021 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/25/2020 - 4 years ago

How cells monitor the integrity of their translation apparatus

Abstract Protein biosynthesis is by far the most energy-consuming process during cellular proliferation; translation accounts for roughly 50% of the energy consumption in growing bacterial, and 30% in differentiating mammalian cells. At the heart of this essential process is the ribosome, the complex molecular machine that catalyzes the peptide bond formation. Therefore, to ensure continuous protein production, cells need to monitor the integrity of their ribosomes. Indeed, throughout the lifetime of the ribosome, its many components are subject to both mechanical and chemical assaults and the accumulated damage can render the ribosome translation-incompetent. At organismal level, alterations in ribosome structure and function have been associated diseases such as neurodegeneration, cancer and ribosomopathies. Although maintaining functional translation apparatus is essential for cell survival, the factors involved in the detection and degradation of faulty ribosomes remain poorly characterized. Studying ribosome surveillance has been hindered by a lack of robust methods for monitoring, purifying, and perturbing specific populations of ribosomes. This proposal aims at exploiting the recent advances in quantitative mass spectrometry, functional genomics methods, and genome editing to identify the factors necessary for coping with 1) defective intermediates during ribosome biogenesis, 2) damaged ribosomes, and 3) specialized ribosomes that have fulfilled their role. This work will advance our knowledge of a fundamental biological process, and improve our understanding of the molecular basis of complex human disease.

IC Name
OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH
  • Activity
    DP5
  • Administering IC
    OD
  • Application Type
    5
  • Direct Cost Amount
    250000
  • Indirect Cost Amount
    153825
  • Total Cost
    403825
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    310
  • Ed Inst. Type
  • Funding ICs
    NIDCR:1\OD:403824\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CARNEGIE INSTITUTION OF WASHINGTON, D.C.
  • Organization Department
  • Organization DUNS
    072641707
  • Organization City
    WASHINGTON
  • Organization State
    DC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    200051910
  • Organization District
    UNITED STATES